Modifiable Risk Factors for Delirium in Critically Ill Trauma Patients: A Multicenter Prospective Study.


Journal

Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 25 3 2017
medline: 25 12 2019
entrez: 25 3 2017
Statut: ppublish

Résumé

Intensive care unit (ICU)-acquired delirium has been associated with increased morbidity and mortality. Prevention strategies including modification of delirium risk factors are emphasized by practice guidelines. No study has specifically evaluated modifiable delirium risk factors in trauma ICU patients. Our goal was to evaluate modifiable risk factors for delirium among trauma patients admitted to the ICU. Prospective observational study. Two level 1 trauma ICU centers. Patients 18 years of age or older admitted for trauma including mild to moderate traumatic brain injury were eligible for the study. Delirium was assessed daily using the confusion assessment method for the ICU (CAM-ICU). The effect of modifiable risk factors was assessed using multivariate Cox regression analysis adjusting for severity of illness and significant nonmodifiable risk factors. A total of 58 of 150 recruited patients (38.7%; 95% confidence interval [CI] 30.9-46.5) screened positive for delirium during ICU stay. When adjusting for significant nonmodifiable risk factors, physical restraints (hazard ratio [HR]: 2.13; 95% CI: 1.07-4.24) and active infection or sepsis (HR: 2.12; 95% CI: 1.18-3.81) significantly increased the risk of delirium, whereas opioids (HR: 0.35; 95% CI: 0.13-0.98), episodes of hypoxia (HR: 0.55; 95% CI: 0.31-0.95), access to a television/radio in the room (HR: 0.26; 95% CI: 0.11-0.62), and number of hours mobilized per day (HR: 0.77; 95% CI: 0.68-0.88) were associated with significantly less risk of delirium. We have identified modifiable risk factors for delirium. Future studies should aim at implementing strategies to modify these risk factors and evaluate their impact on the risk of delirium.

Identifiants

pubmed: 28335673
doi: 10.1177/0885066617698646
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-336

Auteurs

Marc-Alexandre Duceppe (MA)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.

David R Williamson (DR)

2 Pharmacy Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.
3 Faculté de Pharmacie, Université de Montréal, Montreal, Québec, Canada.

Audrée Elliott (A)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.

Mélissa Para (M)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.

Marie-Christine Poirier (MC)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.

Marie-Soleil Delisle (MS)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.

Dan Deckelbaum (D)

4 Department of Traumatology, McGill University Health Centre, Montreal, Québec, Canada.

Tarek Razek (T)

4 Department of Traumatology, McGill University Health Centre, Montreal, Québec, Canada.

Monique Desjardins (M)

5 Department of Psychiatry, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.
6 Faculté de Medicine, Université de Montréal, Montreal, Québec, Canada.

Jean-Claude Bertrand (JC)

5 Department of Psychiatry, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.
6 Faculté de Medicine, Université de Montréal, Montreal, Québec, Canada.

Francis Bernard (F)

6 Faculté de Medicine, Université de Montréal, Montreal, Québec, Canada.
7 Department of Critical Care, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.

Philippe Rico (P)

6 Faculté de Medicine, Université de Montréal, Montreal, Québec, Canada.
7 Department of Critical Care, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.

Lisa Burry (L)

8 Pharmacy Department, Mont Sinai Hospital, Toronto, Ontario, Canada.
9 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

Anne Julie Frenette (AJ)

2 Pharmacy Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Québec, Canada.
3 Faculté de Pharmacie, Université de Montréal, Montreal, Québec, Canada.

Marc Perreault (M)

1 Pharmacy Department, McGill University Health Centre, Montreal, Québec, Canada.
3 Faculté de Pharmacie, Université de Montréal, Montreal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH